You just read:

Foamix Announces Publication of Phase 3 Studies Evaluating FMX103 for the Treatment of Papulopustular Rosacea in Journal of the American Academy of Dermatology

News provided by

Foamix Pharmaceuticals Ltd.

06 Feb, 2020, 16:05 IST